Clinical Trial Update: Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating concurrent Altabax (retapamulin) with topical low-potency corticosteroids versus corticosteroid monotherapy for atopic derma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Altabax (retapamulin)
• Topical low-potency corticosteroids (low-potency corticosteroids)

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Atopic Dermatitis | Phase 4 | Status: WITHDRAWN